Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India
· Delayed Price · Currency is INR 1,963.40
-12.70 (-0.64%)
At close: Dec 5, 2025
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 149.21 billion as of December 5, 2025. Its market cap has decreased by -1.12% in one year.
Market Cap
149.21B
Enterprise Value
140.24B
Revenue
20.42B
Ranking
n/a
PE Ratio
25.34
Stock Price
1,963.40
Market Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 149.21B, an increase of 2,664,925.18%. That is a compound annual growth rate of 53.48%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4,362.71B |
| Divi's Laboratories | 1,713.60B |
| Cipla | 1,228.62B |
| Apollo Hospitals Enterprise | 1,035.39B |
| Zydus Lifesciences | 941.58B |
| Mankind Pharma | 910.67B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |